COVID-19 SARS-CoV-2 Ag Test

Our SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens collected from individuals suspected of COVID-19 within the first 12 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19. Used with the LumiraDx Platform the test delivers rapid results.

This assay uses SARS-CoV-2 specific antibodies in a particle-particle immunoassay to determine the presence of SARS-CoV-2 Nucleocapsid Protein (NP) antigen present in the test sample.

The LumiraDx SARS-CoV-2 Test was found not to cross-react with a panel of organisms and viruses including several human coronaviruses.

Testing for Businesses

We are committed to helping businesses keep their employees safe. If you are interested in getting your employees tested please click here.

Scroll to top